ARMISTICE CAPITAL, LLC - Q2 2021 holdings

$5.59 Billion is the total value of ARMISTICE CAPITAL, LLC's 116 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 55.7% .

 Value Shares↓ Weighting
SUPN SellSUPERNUS PHARMACEUTICALS INC$102,346,000
+14.6%
3,324,000
-2.6%
1.83%
-10.7%
REGN SellREGENERON PHARMACEUTICALS$87,132,000
+5.2%
156,000
-10.9%
1.56%
-17.9%
INCY SellINCYTE CORP$81,101,000
-3.3%
964,000
-6.6%
1.45%
-24.6%
MDT SellMEDTRONIC PLC$64,051,000
+1.2%
516,000
-3.7%
1.15%
-21.1%
BLUE SellBLUEBIRD BIO INC$58,715,000
-0.8%
1,836,000
-6.5%
1.05%
-22.7%
VNDA SellVANDA PHARMACEUTICALS INC$58,378,000
+2.4%
2,714,000
-28.5%
1.04%
-20.2%
BHVN SellBIOHAVEN PHARMACTL HLDG CO L$48,540,000
-29.0%
500,000
-50.0%
0.87%
-44.6%
KO SellCOCA COLA CO$44,586,000
-7.7%
824,000
-10.0%
0.80%
-28.0%
PFE SellPFIZER INC$40,100,000
-7.8%
1,024,000
-14.7%
0.72%
-28.1%
UNH SellUNITEDHEALTH GROUP INC$40,044,000
-20.9%
100,000
-26.5%
0.72%
-38.3%
CENTA SellCENTRAL GARDEN & PET COcl a non-vtg$36,515,000
-11.1%
756,000
-4.5%
0.65%
-30.7%
OCDX SellORTHO CLINICAL DIAGNOSTICS H$35,798,000
-15.5%
1,672,000
-23.9%
0.64%
-34.1%
BUD SellANHEUSER BUSCH INBEV SA/NVsponsored adr$32,837,000
-25.4%
456,000
-34.9%
0.59%
-41.8%
WMT SellWALMART INC$30,779,000
-46.3%
218,261
-48.3%
0.55%
-58.2%
MDLZ SellMONDELEZ INTL INCcl a$28,472,000
-9.2%
456,000
-14.9%
0.51%
-29.2%
MSFT SellMICROSOFT CORP$26,006,000
+2.1%
96,000
-11.1%
0.47%
-20.3%
NTRA SellNATERA INC$25,430,000
+1.0%
224,000
-9.7%
0.46%
-21.3%
DXCM SellDEXCOM INC$24,766,000
-16.0%
58,000
-29.3%
0.44%
-34.6%
AXNX SellAXONICS INC$23,969,000
-4.3%
378,000
-9.6%
0.43%
-25.4%
ILMN SellILLUMINA INC$20,821,000
+12.9%
44,000
-8.3%
0.37%
-11.8%
NUVA SellNUVASIVE INC$20,063,000
-23.5%
296,000
-26.0%
0.36%
-40.4%
BNTX SellBIONTECH SEsponsored ads$14,328,000
-52.5%
64,000
-76.8%
0.26%
-63.0%
FREE SellWHOLE EARTH BRANDS INC$11,890,000
-24.0%
820,000
-31.7%
0.21%
-40.7%
BIO SellBIO RAD LABS INCcl a$11,597,000
-46.6%
18,000
-52.6%
0.21%
-58.2%
ASMB SellASSEMBLY BIOSCIENCES INC$8,629,000
-16.1%
2,224,000
-0.5%
0.15%
-34.7%
BCTXW SellBRIACELL THERAPEUTICS CORP*w exp 02/24/202$675,000
+50.0%
375,000
-10.8%
0.01%
+20.0%
XELA SellEXELA TECHNOLOGIES INC$478,000
-87.9%
200,000
-89.0%
0.01%
-90.1%
AUUDW ExitAUDDIA INC*w exp 10/17/202$0-30,400
-100.0%
0.00%
CUENW ExitCUENTAS INC*w exp 99/99/999$0-50,000
-100.0%
-0.00%
RZLT ExitREZOLUTE INC$0-288,000
-100.0%
-0.05%
PBPB ExitPOTBELLY CORP$0-407,099
-100.0%
-0.06%
ExitPREDICTIVE ONCOLOGY INC$0-2,051,284
-100.0%
-0.06%
FTEK ExitFUEL TECH INC$0-850,000
-100.0%
-0.06%
ExitOBALON THERAPEUTICS INC$0-1,100,000
-100.0%
-0.07%
PRFX ExitPAINREFORM LTD$0-839,346
-100.0%
-0.08%
HOTH ExitHOTH THERAPEUTICS INC$0-2,270,000
-100.0%
-0.10%
RWLK ExitREWALK ROBOTICS LTD$0-1,911,264
-100.0%
-0.11%
PLAN ExitANAPLAN INC$0-132,000
-100.0%
-0.16%
DT ExitDYNATRACE INC$0-150,000
-100.0%
-0.17%
ALT ExitALTIMMUNE INC$0-536,000
-100.0%
-0.17%
SILK ExitSILK RD MED INC$0-150,000
-100.0%
-0.17%
EGRX ExitEAGLE PHARMACEUTICALS INC$0-192,000
-100.0%
-0.18%
WDAY ExitWORKDAY INCcl a$0-35,000
-100.0%
-0.20%
TNDM ExitTANDEM DIABETES CARE INC$0-100,000
-100.0%
-0.20%
BGS ExitB & G FOODS INC NEW$0-288,000
-100.0%
-0.20%
AEO ExitAMERICAN EAGLE OUTFITTERS IN$0-387,995
-100.0%
-0.26%
UAA ExitUNDER ARMOUR INCcl a$0-566,881
-100.0%
-0.29%
POOL ExitPOOL CORP$0-36,875
-100.0%
-0.29%
FIVE ExitFIVE BELOW INC$0-66,800
-100.0%
-0.29%
GPS ExitGAP INC$0-515,617
-100.0%
-0.35%
AVTR ExitAVANTOR INC$0-636,000
-100.0%
-0.42%
POST ExitPOST HLDGS INC$0-188,000
-100.0%
-0.46%
TSCO ExitTRACTOR SUPPLY CO$0-132,737
-100.0%
-0.54%
ADBE ExitADOBE SYSTEMS INCORPORATED$0-54,000
-100.0%
-0.59%
RL ExitRALPH LAUREN CORPcl a$0-290,517
-100.0%
-0.82%
NKE ExitNIKE INCcl b$0-322,491
-100.0%
-0.98%
AAP ExitADVANCE AUTO PARTS INC$0-273,469
-100.0%
-1.15%
LNTH ExitLANTHEUS HLDGS INC$0-2,700,000
-100.0%
-1.32%
TJX ExitTJX COS INC NEW$0-1,128,122
-100.0%
-1.71%
IWM ExitISHARES TRput$0-2,000,000
-100.0%
-10.14%
SPY ExitSPDR S&P 500 ETF TRput$0-2,000,000
-100.0%
-18.20%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ENANTA PHARMACEUTICALS INC30Q3 20232.7%
SPDR S&P 500 ETF TR28Q3 202329.5%
MADRIGAL PHARMACEUTICALS INC27Q3 20232.9%
VANDA PHARMACEUTICALS INC26Q3 20219.4%
REGENERON PHARMACEUTICALS25Q3 20233.2%
ENERGIZER HLDGS INC NEW22Q2 20233.7%
ANTARES PHARMA INC21Q3 20206.6%
INCYTE CORP21Q3 20232.8%
VOYAGER THERAPEUTICS INC21Q3 20232.0%
BLUEBIRD BIO INC20Q4 20211.8%

View ARMISTICE CAPITAL, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ARMISTICE CAPITAL, LLC Q2 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Avalo Therapeutics, Inc.June 28, 2023588,8504.7%
Addex Therapeutics Ltd.February 16, 2023675,2955.0%
Arcadia Biosciences, Inc.February 14, 20232,675,40910.0%
Avinger IncFebruary 14, 2023789,40010.0%
Baudax Bio, Inc.February 14, 20231,165,7095.0%
BIORA THERAPEUTICS, INC.February 14, 202312,989,6485.7%
Bit Digital, IncFebruary 14, 20233,161,8893.7%
Bruush Oral Care Inc.February 14, 20231,122,92210.0%
CATALYST PHARMACEUTICALS, INC.Sold outFebruary 14, 202300.0%
Clarus Therapeutics Holdings, Inc.February 14, 20232,732,1695.0%

View ARMISTICE CAPITAL, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View ARMISTICE CAPITAL, LLC's complete filings history.

Compare quarters

Export ARMISTICE CAPITAL, LLC's holdings